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ABSTRACT 
 
DRUG UTILIZATION STUDY OF β2-AGONIST DRUG 
IN ASTHMA PATIENT 
(Study at Dr. Soetomo Hospital Surabaya) 
 
Anindya Carima 
 
Background. Asthma is a hetergenous disease and usually characterized by 
chronic airway inflamation. Another study declare that prevalence of 
asthma in Indonesia were increased. There are many benefit from use β2-
agonist drug for asthma treatment because it has bronchodilator and 
bronchoprotector activity. 
Objectives.The aim of this study are to identify the utilization of β2-agonist 
drug in asthma and Drug Related Problems (DRPs) that occur in using β2-
agonist drug. 
Methods. This study has retrospective observasional method by using 
patient’s Electronic Medical Record(EMR) who are in January-December 
2015 period. All data were analyzed by comparedwith Global Initiative for 
Asthma 2015 (GINA 2015). 
Results. In this study,there are 34 subjects that appropriate with inclusion 
criteria. There are44.11% subject use SABA, 8.84% use LABA,47.05% use 
combination SABA and LABA.β2-agonist drug that mostly used is 
Salbutamol (SABA) and Formoterol (LABA). β2-agonist drug + 
corticosteroid is combination therapy that mostly used in this study. There 
were some administration dose that given by physician according to 
patient’s condition. Problems that potentially occur in this study are adverse 
effect and interaction between β2-agonist with corticosteroid 60.49% and 
with others simpatomimetics agent 39.51%. 
Conclusion.Drug of choicefor asthma treatment are Salbutamol as reliever 
therapy and Formoterol as controller therapy. Administration dose that 
given were appropriate with GINA 2015. None of actual DRPs occured. 
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